Sculptor Capital’s GE HealthCare GEHC Stock Holding History

Sculptor Capital’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-28,224	Closed	-$2.65M	–	338
2024 Q3	$2.65M	Buy	+28,224	New	+$2.37M	0.04%	166

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sculptor Capital's GEHC Position: Q4 2024 in Review

Sculptor Capital sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 28,224 shares — an estimated $2.65M sold.

Sculptor Capital first reported a position in GEHC in Q3 2024 and held it in 1 quarter. The position peaked at $2.65M in Q3 2024. 1,329 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

Sculptor Capital reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
Sculptor Capital sold 28,224 GE HealthCare shares in Q4 2024, an estimated $2.65M.
Sculptor Capital first reported a position in GE HealthCare in Q3 2024 and held it in 1 quarter.
Sculptor Capital's GE HealthCare position peaked at $2.65M in Q3 2024.
1,329 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on Sculptor Capital's 13F filing for Q4 2024, filed 14 Feb 2025.